Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease

Houston, TX, Jun 8, 2023 – (ACN Newswire via SEAPRWire.com) – Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing multiple therapeutic programs intended to enhance Treg function, including biologics, today reported additional biomarker and

More

CHINA trade tumbles in May

BEIJING — China’s exports fell 7.5 percent from a year earlier in May and imports were down 4.5 percent, adding to signs an economic rebound following the end of anti-virus controls is slowing as global demand weakens under pressure from

More